Products of interest

Founding Directors

Medical Information


Track Record

Sinepin (Doxepin) from Pfizer UK December 2006

Dermacort (Hydrocortisone) from Stada (Genus Pharmaceuticals) August 2006

Gygel (Nonoxinol-9) from Janssen-Cilag January 2008

Anacal (Heparinoid) from Stada (Genus Pharmaceuticals) May 2008




Products of Interest

  • Marlborough wishes to acquire and commercially develop niche pharmaceuticals

  • The products will ideally be used in hospitals or a have hospital led prescription base

  • The products are unlikely to have generic competition

  • End stage treatments are of special interest

  • Products should have a major use in the UK

Business Development

- Contract manufacturing partnerships
- UK distribution partnerships
- Partners in major non UK markets


How the company is financed